A recent report that investigated the expression of CBX2 in human cancers showed initial evidence of an oncogenic role [28]; however, the overexpression of both CBX2 and EZH2 in the basal-like subgroup indicates the importance of interplay between PRC1 and PRC2 in endometrial cancer. The gene discussed is CBX2; the disease is endometrial cancer.